Management of Candida infections in liver transplant recipients: current perspectives

References

• Paya CV, Hermans PE, Washington JA 2nd, et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc. 1989;64(5):555–564.
   Web of Science ®Google Scholar
• Arnow PM. Infections following orthotopic liver transplantation. HPB Surgery. 1991;3(4):221–233.
   Google Scholar
• Fishman JA. Infections in solid-organ transplant recipients. N Engl J Med. 2007;357(25):2601–2614.
   PubMed Web of Science ®Google Scholar
• Moreno A, Cervera C, Gavalda J, et al. Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant. 2007;7(11):2579–2586.
   PubMed Web of Science ®Google Scholar
• Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant. 2010;10(6):1420–1427.
   PubMed Web of Science ®Google Scholar
• Rubin RH. Overview: pathogenesis of fungal infections in the organ transplant recipient. Transpl Infect Dis. 2002;4(Suppl 3):12–17.
   Google Scholar
• Singh N, Wagener MM, Cacciarelli TV, Levitsky J. Antifungal management practices in liver transplant recipients. Am J Transplant. 2008;8(2):426–431.
   Web of Science ®Google Scholar
• Eschenauer GA, Lam SW, Carver PL. Antifungal prophylaxis in liver transplant recipients. Liver Transpl. 2009;15(8):842–858.
   Web of Science ®Google Scholar
• Singh N, Wagener MM, Marino IR, Gayowski T. Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation. 2002;73(1):63–67.
   Web of Science ®Google Scholar
• Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011;3(4):83–92.
   Google Scholar
• Fung JJ. Fungal infections in liver transplantation. Transpl Infect Dis. 2002;4(Suppl 3):18–23.
   Google Scholar
• Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–1111.
   PubMed Web of Science ®Google Scholar
• Husain S, Tollemar J, Dominguez EA, et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study. Transplantation. 2003;75(12):2023–2029.
   PubMed Web of Science ®Google Scholar
• Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2010;12(3):220–229.
   PubMed Web of Science ®Google Scholar
• Shoham S, Marr KA. Invasive fungal infections in solid organ transplant recipients. Future Microbiol. 2012;7(5):639–655.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Andes D, Schuster M, et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant. 2006;6(2):386–391.
   Web of Science ®Google Scholar
• Cruciani M, Mengoli C, Malena M, Bosco O, Serpelloni G, Grossi P. Antifungal prophylaxis in liver transplant patients: a systematic review and meta-analysis. Liver Transpl. 2006;12(5):850–858.
   Web of Science ®Google Scholar
• Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheira M. Candida blood stream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009). Int J Antimicrob Agents. 2011;38(1):65–69.
   PubMed Web of Science ®Google Scholar
• Kett DH, Azoulay E, Echeverria PM, Vincent JL. Candida blood stream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med. 2011;39(4):665–670.
   PubMed Web of Science ®Google Scholar
• Yang YL. Virulence factors of Candida species. J Microbiol Immunol Infect. 2003;36(4):223–228.
   PubMedGoogle Scholar
• Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 2011;19(5):241–247.
   PubMed Web of Science ®Google Scholar
• Ganguly S, Mitchell AP. Mucosal biofilms of Candida albicans. Curr Opin Microbiol. 2011;14(4):380–385.
   PubMed Web of Science ®Google Scholar
• Lockhart SR, Wagner D, Iqbal N, et al. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: Transplant-Associated Infections Surveillance Network (TRANSNET), 2001 to 2006. J Clin Microbiol. 2011;49(7):2404–2410.
   PubMed Web of Science ®Google Scholar
• Fishman JA, Rubin RH. Infections in organ-transplant recipients. N Engl J Med. 1998;338(24):1741–1751.
   PubMed Web of Science ®Google Scholar
• Low CY, Rotstein C. Emerging fungal infections in immunocompromised patients. F1000 Med Rep. 2011;3:14.
   PubMedGoogle Scholar
• Rubin RH. Fungal infections in the organ transplant recipient. In: Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical Mycology. 2nd ed. London: Churchill Livingstone; 2009:471–478.
   Google Scholar
• Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–535.
   PubMed Web of Science ®Google Scholar
• Safdar N, Said A, Lucey MR, et al. Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. Clin Infect Dis. 2004;39(4):517–525.
   Web of Science ®Google Scholar
• Asensio A, Ramos A, Cuervas-Mons V, et al. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transplantation. 2008;14(6):799–805.
   Web of Science ®Google Scholar
• Reid GE, Grim SA, Sankary H, Benedetti E, Oberholzer J, Clark NM. Early intra-abdominal infections associated with orthotopic liver transplantation. Transplantation. 2009;87(11):1706–1711.
   Web of Science ®Google Scholar
• Hellinger WC, Crook JE, Heckman MG, et al. Surgical site infection after liver transplantation: risk factors and association with graft loss or death. Transplantation. 2009;87(9):1387–1393.
   Web of Science ®Google Scholar
• Singh N. The current management of infectious diseases in the liver transplant recipient. Clin Liver Dis. 2000;4(3):657–673.
   Google Scholar
• de Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–1821.
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7–14.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Verweij PE, Arendrup MC, et al. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect. 2012;18(Suppl 7):9–18.
   PubMed Web of Science ®Google Scholar
• Hall L, Le Febre KM, Deml SM, Wohlfiel SL, Wengenack NL. Evaluation of the yeast traffic light PNA FISH probes for identification of candida species from positive blood cultures. J Clin Microbiol. 2012;50(4):1446–1448.
   PubMed Web of Science ®Google Scholar
• Spanu T, Posteraro B, Fiori B, et al. Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol. 2012;50(1):176–179.
   PubMed Web of Science ®Google Scholar
• Posteraro B, De Pascale G, Tumbarello M, et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1&#8594)-β-D-glucan assay, Candida score, and colonization index. Crit Care. 2011;15(5):R249.
   PubMed Web of Science ®Google Scholar
• Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1&#8594)-β-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2005;43(12):5957–5962.
   PubMed Web of Science ®Google Scholar
• Chen J, Wang Y, Shen Z, Zhu Z, Song Y, Han R. Early diagnostic value of plasma PCT and BG assay for CRBSI after OLT. Transplant Proc. 2011;43(5):1777–1779.
   Web of Science ®Google Scholar
• Yamanouchi K, Takatsuki M, Hidaka M, Soyama A, Kanematsu T, Eguchi S. Significance of serum β-D-glucan levels in recipients of living donor liver transplantation. J Hepatobiliary Pancreat Sci. 2011;18(3):432–435.
   PubMed Web of Science ®Google Scholar
• Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol. 1999;37(5):1510–1517.
   PubMed Web of Science ®Google Scholar
• Sendid B, Poirot JL, Tabouret M, et al. Combined detection of mannanemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol. 2002;51(5):433–442.
   Web of Science ®Google Scholar
• Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation. Am J Transplant. 2011;11(6):1123–1130.
   Web of Science ®Google Scholar
• Greenwald MA, Kuehnert MJ, Fishman JA. Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis. 2012;18(8):e1.
   Google Scholar
• Singh N, Huprikar S, Burdette SD, Morris MI, Blair JE, Wheat LJ. Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice. Am J Transplant. 2012;12(9):2414–2428.
   PubMed Web of Science ®Google Scholar
• Danzinger-Isakov L, Kumar D. Vaccination in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):311–317.
   Google Scholar
• Edwards JE Jr. Fungal cell wall vaccines: an update. J Med Microbiol. 2012;61(Pt 7):895–903.
   PubMed Web of Science ®Google Scholar
• Schmidt CS, White CJ, Ibrahim AS, et al. NDV-3, a recombinant alum-adjuvanated vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine. 2012;30(52):7594–7600.
   PubMed Web of Science ®Google Scholar
• Sandini S, La Valle R, Deaglio S, Malavasi F, Cassone A, De Bernardis F. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS Immunol Med Microbiol. 2011;62(2):215–224.
   PubMedGoogle Scholar
• Torosantucci A, Chiani P, Bromuro C, et al. Protection by anti-β-glucan antibodies is associated with restricted β-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One. 2009;4(4):e5392.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Clemons KV, Liu M. Developing a vaccine against Aspergillosis. Med Mycol. 2011;49(Suppl 1):170–176.
   PubMed Web of Science ®Google Scholar
• Playford EG, Webster AC, Sorell TC, Craig JC. Antifungal agents for preventing fungal infections in solid organ transplant recipients [review]. Cochrane Database Syst Rev. 2004;3:CD004291.
   Google Scholar
• Saliba F, Delvart V, Ichai P, et al. Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clin Transplant. 2013;27(4):E454–E461.
   PubMed Web of Science ®Google Scholar
• Pappas PG, Silveira FP. Candida in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S173–S179.
   Web of Science ®Google Scholar
• Goff DA, Bauer KA, Mangino JE. Antimicrobial Stewardship Management of Infections: Beyond the Costs of Antimicrobials. New York, NY: Pharmacy Practice News; 2012. Available from: http://www.pharmacypracticenews.com/download/Antimicrobial_stewardship_WM.pdf. Accessed June 5, 2014.
   Google Scholar
• Reed EE, West JE, Keating EA, et al. Improving the management of candidemia through antimicrobial stewardship interventions. Diagn Microbiol Infect Dis. 2014;78(2):157–161.
   Web of Science ®Google Scholar
• Amanda-Rajah MR, Slavin MA, Thursky KT. The case for antifungal stewardship. Curr Opin Infect Dis. 2012;25(1):107–115.
   Web of Science ®Google Scholar
• Ruhnke M. Antifungal stewardship in invasive Candida infections. Clin Microbiol Infect. 2014;20(Suppl 6):11–18.
   PubMed Web of Science ®Google Scholar
• Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect Dis Clin North Am. 2011;25(1):201–225.
   PubMed Web of Science ®Google Scholar
• Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers of Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14.
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011.
   PubMed Web of Science ®Google Scholar
• Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev. 2011;24(1):141–173.
   PubMed Web of Science ®Google Scholar
• Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(Suppl 1):S22–S30.
   Google Scholar
• Pammi M, Eddama O, Weisman LE. Patient isolation measures for infants with Candida colonization or infection for preventing or reducing transmission of Candida in neonatal units [review]. Cochrane Database Syst Rev. 2011;11:CD006068.
   Google Scholar
• Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15(10):1143–1238.
   PubMed Web of Science ®Google Scholar
• Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49(9):3640–3645.
   PubMed Web of Science ®Google Scholar
• Silveira FP, Kusne S. Candida infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):220–227.
   PubMedGoogle Scholar
• Andes DR, Safdar N, Baddley JW, et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54(8):1110–1122.
   PubMed Web of Science ®Google Scholar
• Chen SC, Slavin MA, Sorrell TC. Echinocandin antifungal drugs in fungal infections: a comparison. Drugs. 2011;71(1):11–41.
   PubMed Web of Science ®Google Scholar
• Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med. 2002;347(25):2020–2029.
   PubMed Web of Science ®Google Scholar
• Reboli AC, Rotstein C, Pappas PG, et al. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med. 2007;356(24):2472–2482.
   PubMed Web of Science ®Google Scholar
• Fortun J, Lopez-San Roman A, Velasco JJ, et al. Selection of Candida glabrata strains with reduced susceptibility to azoles in four liver transplant patients with invasive candidiasis. Eur J Clin Microbiol Infect Dis. 1997;16(4):314–318.
   PubMed Web of Science ®Google Scholar
• Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD. Breakthrough invasive candidiasis in patients on micafungin. J Clin Microbiol. 2010;48(7):2373–2380.
   PubMed Web of Science ®Google Scholar
• Lingegowda PB, Tan CK, Tan AL, Tan BH. Selection of resistant fungi in liver transplant recipients during use of newer antifungal agents: a report of two cases. Ann Acad Med Singapore. 2011;40(6):287–290.
   Web of Science ®Google Scholar